Home › Therapeutic areas › Immunology › Rheumatoid Arthritis
Rheumatoid Arthritis (8 companies)
Companies with an active program in Rheumatoid Arthritis.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ANAB | ANAPTYSBIO, INC | DermatologyGI/HepatologyImmunologyOncology Rare | 1 | Approved | 6 |
| ARTV | Artiva Biotherapeutics, Inc. | DermatologyImmunologyOncologyRenal Rare | 1 | Phase 2 | 16 |
| CGEM | Cullinan Therapeutics, Inc. | ImmunologyOncology | 1 | NDA Submitted | 7 |
| IMVT | Immunovant, Inc. | ImmunologyNeurology Rare | 1 | Phase 2 | 6 |
| IXHL | Incannex Healthcare Inc. | ImmunologyNeurologyRespiratory | 1 | Phase 2 | 3 |
| JBIO | Jade Biosciences, Inc. | ImmunologyRenal Rare | 1 | Phase 1 | 5 |
| KYTX | Kyverna Therapeutics, Inc. | ImmunologyNeurologyRenal Rare | 1 | NDA Submitted | 7 |
| SYRE | Spyre Therapeutics, Inc. | Immunology | 1 | Phase 2 | 12 |
No companies match.